Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meilian Fuxin Solution for the Prevention of Radiation Dermatitis
NCT07353671Phase 3Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2026
- Primary completion
- Dec 2026
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of Meilian Fuxin Solution in radiation dermatitis, sponsored by West China Hospital of Sichuan University. Started Mar 2026; status: recruiting.
02
Drugs
Meilian Fuxin Solution
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT07353671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07353671.